This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Muniyappa, R. Articles by Sowers, J. R. Search for Related Content PubMed PubMed Citation Articles by Muniyappa, R. Articles by Sowers, J. R.

(Hypertension. 1998;31:289.)
© 1998 American Heart Association, Inc.

Scientific Contributions

Calcium and Protein Kinase C Mediate High-Glucose-Induced Inhibition of Inducible Nitric Oxide Synthase in Vascular Smooth Muscle Cells

Ranganath Muniyappa; Pothur R. Srinivas; Jeffrey L. Ram; Mary F. Walsh; James R. Sowers

From Departments of Physiology and Internal Medicine, Wayne State University School of Medicine and VA Medical Center, Detroit, Michigan

Correspondence to James R. Sowers, MD, Wayne State University School of Medicine, HC-4H, 4201 St. Antoine, Detroit, MI 48201. E-mail sowers{at}oncgate.roc.wayne.edu

Abnormal vascular smooth muscle (VSMC) proliferation is a key feature in diabetes-associated atherosclerotic disease. Since nitric oxide inhibits VSMC tone, migration, adhesion, and proliferation, we examined the effects of high glucose on IL-1ß-induced NO release from VSMCs in culture. Confluent smooth muscle cells, preincubated with either 5 mmol/L (mM) or 20 mmol/L (mM) glucose for 48 hours, were stimulated with IL-1ß. Nitrite was measured in the culture medium after 24 hours. IL-1ß-induced a 15-fold increase in NO production in normal glucose medium. Glucose (10 to 30 mmol/L (mM)) significantly reduced the response to IL-1ß. High glucose (20 mmol/L (mM) inhibited IL-1ß-evoked NO production by approximately 50%. IL-1ß-stimulated [³H] citrulline-forming activity of the nitric oxide synthase (NOS) was also significantly lower in high-glucose-exposed cells, and this was reflected in diminished cellular levels of NOS protein. To assess the role of protein kinase C (PKC), membrane PKC activity was measured, and glucose (20 mmol/L (mM)) significantly increased it. Immunoblotting of the membranes revealed a glucose-induced increase in the PKC ßII isoform. 1,2-Dioctanoyl-glycerol, a PKC activator, mimicked the high-glucose effect on IL-1ß-induced NO release, while staurosporine, a PKC inhibitor, reversed it. The role of calcium in the glucose-mediated inhibition of cytokine-induced NO release was determined by treatment with BAPTA, an intracellular chelator of calcium. BAPTA partially reversed the inhibitory effects of glucose. Increasing intracellular calcium by A23187, an ionophore or thapsigargin, an inhibitor of endoplasmic reticulum Ca²⁺-ATPase, significantly decreased IL-1ß-induced NO release and NOS expression. These results indicate that glucose-induced inhibition of IL-1ß-stimulated NO release and NOS expression may be mediated by PKC activation and increased intracellular calcium.

Key Words: protein kinase C • nitric oxide synthase • muscle • smooth • vascular • calcium • hyperglycemia

Abbreviations: DAG = 1,2-diacyl-sn-glycerol • cNOS = calcium/calmodulin-dependent NOS • DAG = diacylglycerol • DOG = 1,2-dioctanoyl-sn-glycerol • HG = high glucose • iNOS = calcium-independent NOS • NG = normal glucose • NO = nitric oxide • NOS = nitric oxide synthase • PKC = protein kinase C • PMSF = phenylmethylsulfonylfluoride • VSMC = vascular smooth muscle cells

This article has been cited by other articles:

				A. Maggi, A. Cignarella, A. Brusadelli, C. Bolego, C. Pinna, and L. Puglisi Diabetes Undermines Estrogen Control of Inducible Nitric Oxide Synthase Function in Rat Aortic Smooth Muscle Cells Through Overexpression of Estrogen Receptor-{beta} Circulation, July 15, 2003; 108(2): 211 - 217. [Abstract] [Full Text] [PDF]

				H. Sakuma, M. Yamamoto, M. Okumura, T. Kojima, T. Maruyama, and K. Yasuda High glucose inhibits apoptosis in human coronary artery smooth muscle cells by increasing bcl-xL and bfl-1/A1 Am J Physiol Cell Physiol, August 1, 2002; 283(2): C422 - C428. [Abstract] [Full Text] [PDF]

				M. Meier and G. L King Protein kinase C activation and its pharmacological inhibition in vascular disease Vascular Medicine, August 1, 2000; 5(3): 173 - 185. [Abstract] [PDF]

				R. Muniyappa, R. Xu, J. L. Ram, and J. R. Sowers Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1762 - H1768. [Abstract] [Full Text] [PDF]

				M. B. Ganz and A. Seftel Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E146 - E152. [Abstract] [Full Text] [PDF]

				K. M. WARPEHA, W. XU, L. LIU, I. G. CHARLES, C. C. PATTERSON, F. AH-FAT, S. HARDING, P. M. HART, U. CHAKRAVARTHY, and A. E. HUGHES Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic retinopathy FASEB J, October 1, 1999; 13(13): 1825 - 1832. [Abstract] [Full Text]

				K. B. Jourdan, T. W. Evans, N. J. Lamb, P. Goldstraw, and J. A. Mitchell Autocrine Function of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Proliferation of Human and Rat Pulmonary Artery Smooth-Muscle Cells . Species Variation Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 105 - 110. [Abstract] [Full Text]

				S. M. Fitzgerald and M. W. Brands Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1070 - R1076. [Abstract] [Full Text] [PDF]

				J. A. Beckman, A. B. Goldfine, M. B. Gordon, L. A. Garrett, and M. A. Creager Inhibition of Protein Kinase C{beta} Prevents Impaired Endothelium-Dependent Vasodilation Caused by Hyperglycemia in Humans Circ. Res., January 11, 2002; 90(1): 107 - 111. [Abstract] [Full Text] [PDF]